ACE-011

· Celgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACE-011, covering 2024-10-03 to 2024-10-03. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma [Phase 2]

See pricing